Facebook-f Twitter Tiktok Instagram Youtube
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Float Short %

7.01

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

0.82

Price

0.01

Target Price

100

Analyst Recom

2

Performance Q

-53.7

Relative Volume

Beta

1.01

Ticker: TRVN



19 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2025-12-09TRVN0.012N/AN/A0
2025-12-10TRVN0.012N/AN/A0
2025-12-11TRVN0.012N/AN/A0
2025-12-12TRVN0.012N/AN/A0
2025-12-15TRVN0.012N/AN/A0
2025-12-16TRVN0.012N/AN/A0
2025-12-17TRVN0.012N/AN/A0
2025-12-18TRVN0.012N/AN/A0
2025-12-19TRVN0.012N/AN/A0
2025-12-22TRVN0.012N/AN/A0
2025-12-23TRVN0.012N/AN/A0
2025-12-26TRVN0.012N/AN/A0
2025-12-29TRVN0.012N/AN/A0
2025-12-30TRVN0.012N/AN/A0
2025-12-31TRVN0.012N/AN/A0
2026-01-02TRVN0.012N/AN/A0
2026-01-05TRVN0.012N/AN/A0
2026-01-06TRVN0.012N/AN/A0
2026-01-07TRVN0.012N/AN/A0
DateSymbolLatestP/C OIP/C VolTotal OI
19 items Current Page1 of 1



19 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-12-09TRVN0.01- - -1.72
2025-12-10TRVN0.01- - -1.72
2025-12-11TRVN0.01- - -1.72
2025-12-12TRVN0.01- - -1.72
2025-12-15TRVN0.01- - -1.72
2025-12-16TRVN0.01- - -1.72
2025-12-17TRVN0.01- - -1.72
2025-12-18TRVN0.01- - -1.72
2025-12-19TRVN0.01- - -1.72
2025-12-22TRVN0.01- - -1.72
2025-12-23TRVN0.01- - -1.72
2025-12-26TRVN0.01- - -1.72
2025-12-29TRVN0.01- - -1.72
2025-12-30TRVN0.01- - -1.72
2025-12-31TRVN0.01- - -1.72
2026-01-02TRVN0.01- - -1.72
2026-01-05TRVN0.01- - -1.72
2026-01-06TRVN0.01- - -1.72
2026-01-07TRVN0.01- - -1.72
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
19 items Current Page1 of 1



No data found

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

-0.47

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

1.01

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

6

Growth Score

Sentiment Score

30

Actual DrawDown %

98.7

Max Drawdown 5-Year %

Target Price

100

P/E

Forward P/E

PEG

P/S

4.81

P/B

P/Free Cash Flow

EPS

-56.5

Average EPS Est. Cur. Y​

-1.72

EPS Next Y. (Est.)

-0.9

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

118.9

Return on Equity vs Industry %

134.1

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.42

EBIT Estimation

Trevena, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 23
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV734, a small molecule G protein biased ligand of the MOR, which has completed phase I studies for the treatment of moderate-to-severe acute and chronic pain; and TRV045, a novel S1P modulator for managing chronic pain. Trevena, Inc. was incorporated in 2007 and is headquartered in Chesterbrook, Pennsylvania.
stock quote shares TRVN – Trevena, Inc. Stock Price stock today
news today TRVN – Trevena, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch TRVN – Trevena, Inc. yahoo finance google finance
stock history TRVN – Trevena, Inc. invest stock market
stock prices TRVN premarket after hours
ticker TRVN fair value insiders trading